This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
as a director of molecularbiology. a biotech company focused on yeast-based antibody discovery, and served as president and CEO from 2000 to 2005. Before joining GenScript, Zhu worked at California-based Clontech Laboratories, Inc. Zhu founded Genetastix Corporation, Inc., Most read today on BioSpace: Source link.
He majored in biological chemistry at the University of Chicago and during his junior year, he had a fortuitous meeting with his academic advisor about finding a student research position that would let him dive more deeply into the molecular details of biological systems. A combined MD/PhD program offered both opportunities.
Dr Rochlin earned a PhD in MolecularBiology and Genetics from Weill Cornell Medical College, conducting research at Sloan Kettering Institute, and a BA in Biology from the University of Pennsylvania. Chem Immunol Allergy 86:151-183 (2005). and MBA students with real-world consulting experiences. Cells 9(40):800 (2020).
Yesse Technologies’ core technology, the ORion21 genetic platform, is the product of over 30 years of fundamental research on the molecularbiology of the sense of smell and is exclusively licensed from The City University of New York. This mission is at the core of the Center of Expertise as well. View original content: [link].
Within close propinquity to AstraZeneca’s new centre is the University of Cambridge’s School of Clinical Medicine, the Medical Research Council Laboratory of MolecularBiology, Cancer Research UK and the Royal Papworth and Addenbrooke’s Hospitals, among others.
” Foundations Basics of Synthetic Biology →Foundations for engineering biology , by Endy D. Nature (2005). Link →A brief history of synthetic biology , by Cameron D.E. Link Synthetic biology: applications come of age , by Khalil A.S. & Journal of MolecularBiology (1961).
” Foundations Basics of Synthetic Biology →Foundations for engineering biology , by Endy D. Nature (2005). Link →A brief history of synthetic biology , by Cameron D.E. Link Synthetic biology: applications come of age , by Khalil A.S. & Journal of MolecularBiology (1961).
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content